USRE43006E1 - Aryl-acrylic acid esters - Google Patents

Aryl-acrylic acid esters Download PDF

Info

Publication number
USRE43006E1
USRE43006E1 US10/209,628 US20962802A USRE43006E US RE43006 E1 USRE43006 E1 US RE43006E1 US 20962802 A US20962802 A US 20962802A US RE43006 E USRE43006 E US RE43006E
Authority
US
United States
Prior art keywords
residue
formula
branched
phenyl
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US10/209,628
Inventor
Denise Anderson
Georg Frater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
Givaudan Roure International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givaudan Roure International SA filed Critical Givaudan Roure International SA
Priority to US10/209,628 priority Critical patent/USRE43006E1/en
Application granted granted Critical
Publication of USRE43006E1 publication Critical patent/USRE43006E1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/44—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by unsaturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50—Perfumes
    • C11D3/502—Protected perfumes
    • C11D3/507—Compounds releasing perfumes by thermal or chemical activation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Definitions

  • the present invention relates to 3-(2-substituted aryl)-acrylic acid esters, especially 3-(2-hydroxyaryl)-acrylic acid esters and 3-(2-aminoaryl)-acrylic acid esters.
  • These compounds are useful as precursors for organoleptic compounds, such as for example, flavors, fragrances and masking agents, antimicrobial compounds and fluorescent whitening agents.
  • a principal strategy currently employed for imparting odors, such as fragrance, to consumer products is to admix the fragrance directly into the product.
  • the fragrance material can be too volatile and/or too soluble, resulting in fragrance loss during manufacturing, storage, and use.
  • many fragrance materials are also unstable over time which, again, results in loss during storage.
  • Microencapsulation and inclusion complexes with cyclodextrins have been used to help decrease volatility, improve stability and provide slow-release properties. These methods are, for a number of reasons, often not successful and/or too expensive to be commercially viable, as for example, in the case of cyclodextrins.
  • Fragrance precursors for scenting fabrics being washed in the presence of a lipase-containing detergent are described in WO 95/04809.
  • the fragrance precursors contained in the detergent and/or in the softener are cleaved by the lipase and a single active compound. In such a situation, an odoriferous alcohol, aldehyde or ketone is produced. In this system, a prolonged scenting effect on the fabric is obtained.
  • the need for a lipase-containing detergent is of limited commercial significance. In many parts of the world, detergents do not contain lipase. Other consumers prefer to use so-called ‘nonbio’ detergents.
  • Fluorescent whitening agents or brighteners have been added to laundry detergents since the 1950s to help maintain the original brightness of white clothing.
  • one object of the present invention is to provide new precursors for compounds with different activities. Through these precursors, different activities are imparted to a product by the addition of just one compound of the present invention.
  • Another object of the invention is to provide new precursor compounds which are stable under transport and storage conditions.
  • a further object of the present invention is to provide new precursors that supply different active compounds simultaneously or successively.
  • the present invention provides compounds of the Formula I
  • A is a benzene or a naphthalene ring
  • R 1 is, or is selected from saturated, unsaturated, straight, branched, alicyclic and/or aromatic C 10 -C 30 hydrocarbon residues which can contain heteroatoms and can be substituted by an ionic substituent
  • R 2 in the 2- or 3-position is, or is selected from hydrogen, a straight or branched C 1 -C 6 residue, an optionally substituted aromatic and/or optionally substituted heterocyclic residue
  • R 3 and R 4 are, or selected from hydrogen, a straight or branched C 1 -C 6 alkyl, a C 1 -C 6 alkoxy residue, a substituted or condensed heterocyclic residue, —OH, —NO 2 , —NH 2 , —N(C 1 -C 6 alkyl) 2 , —N(hydroxyalkyl) 2 , —NHCO 2 CH 3 and/or —NH (heterocycle).
  • R 2 , R 3 and R 4 are the same or different.
  • X is, or is selected from —OH and/or NHR 6 , wherein R 6 is, or is selected from hydrogen, a saturated or unsaturated, straight or branched C 1 -C 20 hydrocarbon and/or an optionally substituted aromatic or heterocyclic residue; and the acrylic double bond is of the E configuration.
  • the present invention also provides a method for preparing organoleptic, antimicrobial and fluorescent whitening compositions by incorporating into these precursor compounds of Formula I described above.
  • the present invention provides novel 3-(2-substituted aryl)-acrylic acid esters of the Formula I set forth below:
  • Formula I includes all possible enantiomers, diastereomers and all mixtures thereof.
  • R 1 is preferably a saturated or unsaturated, straight or branched C 10 -C 30 hydrocarbon residue containing one or more O and/or N atoms and/or C(O) groups and/or alkoxy groups or substituted by an ionic substituent of the formula N(R 5 ) 3 + , in which R 5 is the residue of a fatty acid or an alkyl group with 1 to 30 carbon atoms are preferred.
  • R 2 is preferably a heterocyclic residue of the formula
  • R 3 and/or R 4 are preferably hydrogen, —N(C 1 -C 6 alkyl 2 , —NH 2 , a five membered heterocyclic residue optionally containing N and/or O atoms, substituted by C 1 -C 6 aliphatic and/or aromatic substituents.
  • R 1 is preferably the residue of an olfactory alcohol of the formula R 1 OH, of the enol form of an olfactory aldehyde of the formula R 1 is an optionally substituted alkyl, alkenyl or arylalkyl residue carrying an 1-alkoxy, 1-aryloxy, or 1-arylakoxy residue.
  • compounds within the scope of Formula I are mostly or nearly odorless at room temperature, atmospheric conditions and about 20 to 100% relative humidity. Under activating conditions, however, compounds of Formula I are cleaved to form active compounds. For example, the residue of Formula Ia when cleaved forms a coumarin of Formula II.
  • X 1 is O or NR 6 ;
  • R 2 , R 3 , R 4 are defined as set forth above.
  • the coumarins of Formula II have organoleptic, antimicrobial and/or optical brightening activity.
  • coumarins of the present invention have olfactory properties.
  • R 1 is the residue of an olfactory alcohol or the enol form of an olfactory aldehyde or ketone
  • R 1 is the residue of an olfactory alcohol or the enol form of an olfactory aldehyde or ketone
  • the compounds of Formula I permit the development of useful consumer products with enhanced organoleptic, antimicrobial and/or optical brightening properties.
  • the organoleptic coumarins, alcohols, aldehydes and ketones obtained from the present compounds are useful, for example, in preparing fragrances, flavors, masking agents and antimicrobial agents.
  • active residues from Formula I and Ia these compounds are subject to activating conditions that lead to the cleavage of thereof.
  • actinic radiation such as, UV light, including sunlight can be used to activate the compounds of Formula I.
  • Elevated temperatures also function to activate the compounds of Formula I and Ia.
  • any activating condition may be used, so long as the desired active ingredients are formed by cleavage of compounds of Formula I and Ia to form the desired residue with the proper activity
  • organoleptic precursors include, for example, precursors compatible in flavors, fragrances and odor masking agents.
  • the esters of formula I can act as fragrance precursors in laundry products. They can also act as precursors for odor masking agents in the same products as the fragrance precursors. They also can act as precursors for antimicrobial agents. In addition, they can also act as precursors for fluorescent whitening agents.
  • the fragrance precursors and the precursors for odor masking agents as well as the flavor precursors of the invention may be used individually in an amount effective to enhance or to mask the characteristic odor or flavor of a material. More commonly, however, the compounds are mixed with other fragrance or flavor components in an amount sufficient to provide the desired odor or flavor characteristics.
  • an “effective” amount is intended to mean a sufficient quantity of the precursor to obtain the desired effect, i.e., fragrance, odor masking and/or flavoring. Reference is made to the Examples set forth below and to the skill of the art for determining an effective amount of the present inventive compounds in any given situation.
  • the brightener precursors may also be employed individually in an effective amount where appropriate, and/or mixed with one or more other brightener or colorant substance.
  • the desired effect is prolonged and the substantivity on different substrates is enhanced.
  • two active compounds are provided by one ester of the Formula I, they can be generated, depending on the precursor and/or the activating conditions, simultaneously or successively. Further, the precursors of the present invention provide slow release of the active compounds.
  • Non-limiting examples of alcohols R 1 OH generated upon cleavage of compounds of Formula I and constituting the residue R 1 include amyl alcohol, hexyl alcohol*, 2-hexyl alcohol*, heptyl alcohol*, octyl alcohol*, nonyl alcohol*, decyl alcohol* undecyl alcohol*, lauryl alcohol*, myristic alcohol, 3-methyl-but-2-en-1-ol*, 3-methyl-1-pentanol, cis-3-hexenol*, cis-4-hexenol*, 3,5,5-trimethyl-hexanol, 3,4,5,6,6-pentamethylheptan-2-ol*, citronellol*, geraniol*, oct-1-en-3-ol, 2,5,7-trimethyl-octan-3-ol, 2-cis-3,7-dimethyl-2,6-octadien-1-ol, 6-ethyl-3-methyl-5
  • the alcohols identified with an asterisk are preferred embodiments, and the alcohols identified with two asterisks are more preferred.
  • Non-limiting examples of aldehydes R 1 HO generated upon cleavage a compound of Formula I and constituting the residue R 1 thereof include, for example, 2,6,10-trimethylundec-9-enal*, 1,2,3,4,5,6,7,8-octahydro-8,8-dimethyl-2-napthalenecarboxaldehyde tridecanal, 2-[4-(1-methylethyl)phenyl]-ethanal, 2,4-dimethyl-cyclohex-3-ene-1-carbox-aldehyde*, 4-carboxaldehyde-1,3,5-trimethyl-cyclohex-1-ene*, 1-carboxaldehyde-2,4-dimethyl-cyclohex-3-ene*, 1-carboxaldehyde-4-(4-hydroxy-4-methylpentyl)-cyclohex-3-ene*, 3,5,5-trimethyl-hexanal, heptanal*, 2,6-di
  • the aldehydes identified with an asterisk are preferred embodiments, and the alcohols identified with two asterisks are more preferred.
  • ketones R 1 O generated upon cleavage a compound of Formula I and constituting the residue R 1 thereof include, for example, 2-heptyl-cyclopentanone, 2,2,6,10-tetrametyltricyclo-[5.4.0.0(6,10)]-undecan-4-one benzylacetone*, carvone*, 1,2,3,5,6,7-hexahydro-1,1,2,3,3-pentamentyl-4H-inden-4-one*, methyl heptenone*, dimethyl octenone*, 2-(butan-2-yl)-cyclohexanone*, 2-hexyl-cyclopent-2-en-1-one*, 2-(1-methylethyl)-5-methyl-cyclohexanone*, 2-(2-methylethyl)-5-methyl-cyclohexanone*, 3-methyl-cyclopentadecanone, 4-tert-pentyl-cyclohexanone*, 3-oxo-2-p
  • ketones identified with an asterisk are preferred embodiments, and the alcohols identified with two asterisks are more preferred.
  • Non-limiting examples of fluorescent whitening coumarins generated upon cleavage a compound of Formula I and constituting the residue R 1 thereof include, for example, 7-(3-methyl-1H-pyrazol-1-yl)-3-phenyl-2H-1-benzopyran-2-one, 7-(4-methyl-5-phenyl-2H-1,2,3-triazol-2-yl)-3-phenyl-2H-1-benzopyran-2-one, 7-(2H-naphtho[1,2-d]triazol-2-yl)-3-phenyl-2H-1-benzo-pyran-2-one, 3-(1H-pyrazol-1-yl)-7-(2H-1,2,3-triazol-2-yl)-2H-1-benzo-pyran-2-one, 7-(dimethylamino)-1-methyl-3-phenyl-2(1H)-quinolinone, 7-(diethylamino)-1-ethyl-3-phenyl-2(1
  • Non-limiting examples of coumarins of Formula II having olfactory properties generated upon cleavage and constituting the respective residue in the compounds of Formula I include 2H-1-benzopyran, 3-methyl-benzopyran-2-one, 8-(1,1-dimethylethyl)-6-methyl-benzopyrone, 4-methyl-7-ethoxy-coumarin and 6-methyl-2H-1-benzopyran.
  • the active coumarins, alcohols, aldehydes and ketones which are generated as a result of the desired cleavage of the acrylic acid esters of Formula I by UV-light and/or by elevated temperatures is exemplary only and is not intended to limit the scope of the present invention in any way.
  • the compounds of Formula I may be employed in preparing sustained release odorants and flavors.
  • the compounds of Formula I also are useful as sustained agents which may be employed to mask or attenuate undesirable odors or to provide additional odors not initially present in consumer products including for example, laundry detergents, fabric softeners, fabric softener sheets, toiletries and cosmetics such as sunscreens.
  • compositions of Formula I include sustained brighteners and antimicrobial agents in the same products.
  • the brighteners are especially useful for wool, rayon and polyamides. These compounds are also useful for flavoring and aromatizing tobacco products, such as for example, cigarettes.
  • the amount of the compounds of the present invention required to produce the desired, overall effect varies depending upon the particular compounds of Formula I chosen, the product in which it will be used, and the particular effect desired.
  • the examples teach what amounts are suitable for any desired purpose.
  • a compound of Formula I when added either singly or as a mixture to, for example, a laundry product composition at levels ranging from about 0.001 to about 10% by weight, a coumarin and if desired an odoriferous alcohol, aldehyde or ketone in an organoleptically effective amount is released when the product is used.
  • odoriferous alcohol, aldehyde or ketone in an organoleptically effective amount is released when the product is used.
  • an antimicrobial agent and/or a brightener can be released.
  • Formula I compounds Depending upon the selection and concentration, addition of the Formula I compounds, either singly or as a mixture, to cigarette tobacco at levels ranging from about 5 ppm to about 50,000 ppm tends to enhance the smoking flavor and/or mask undesirable smoking odors.
  • An important property of these Formula I compounds is that the flavorant or odorant is covalently bound as a non-volatile compound and the flavorant or odorant is released only when the tobacco product is ignited and burns.
  • precursors of the invention may be used according to methods known to the perfumer, such as e.g. from W. A. Poucher, Perfumes, Cosmetics, Soaps, 2, 7th Edition, Chapman and Hall, London 1974 which is hereby incorporated by reference.
  • the fluorescent whitening agents may be added in similar manner.
  • Examples 1-4 yield upon cleavage organoleptic coumarins, Examples 5 and 6 organoleptic coumarins and organoleptic alcohols and Example 7 a brightener coumarin
  • 3-(2-hydroxy-phenyl)-acrylic acid 2-ethyl-4-(2,2,3-trimethyl-cyclopent-3-enyl)-but-2-enyl ester was prepared from 3-(2-hydroxy-phenyl)-acrylic acid ethyl ester, 2-ethyl-4(2,2,3-trimethyl cyclopentyl-3-en-1-yl)-but-2-en-1-ol and tetraisopropyl-o-titanate.
  • 3-(2-hydroxy-5-methyl-phenyl)-acrylic acid 2-ethyl-4-(2,2,3-trimethyl-cyclopent-3-enyl)-but-2-enyl ester was prepared from 3-(2-hydroxy-5-methyl-phenyl)-acrylic acid ethyl ester, 2-ethyl-4(2,2,3-trimethyl cyclopentyl-3-en-1-yl)-but-2-en-1-ol and tetraisopropyl-o-titanate.
  • 3-(2-hydroxy-5-methyl-phenyl)-acrylic acid 3-methyl-5-phenyl-pentyl ester was prepared from 3-(2-hydroxy-.5-methyl-phenyl)-acrylic acid ethyl ester, 3-methyl-5-phenyl-pentanol and tetraisopropyl-o-titanate.
  • 3-(4-diethylamino-2-hydroxy-phenyl)-but-2-enoic acid dec-9-enyl ester was prepared from 3-(4-diethylamino-2-hydroxy-phenyl)-but-2-enoic acid ethyl ester, dec-9-en-1-ol and tetraisopropyl-o-titanate.
  • 3-(4-diethylamino-2-hydroxy-phenyl)-but-2-enoic acid 3-methyl-5-phenyl-pentyl ester was prepared from 3-(4-diethylamino-2-hydroxy-phenyl)-but-2-enoic acid ethyl ester, 3-methyl-5-phenyl-pentanol and tetraisopropyl-o-titanate.
  • Test cloth was washed with detergent to which one or more of the precursors of Examples 1-14 had been added. The cloth was then line dried. The cloth dried in sunlight had a distinct fragrance note, as determined by a trained panel. In contrast, the cloth dried without sunlight was olfactively neutral.
  • Test cloth was washed with a detergent and then a fabric softener, containing one ore more of the precursors of Examples 1-14, was added to the rinse cycle. The cloth was then line dried. The cloth dried in sunlight had a distinct fragrance note, as determined by a trained panel. In contrast, the cloth dried without sunlight was olfactively neutral.
  • a 1% solution of one or more of the products of Examples 1-14 in ethanol was applied to cigarette papers to produce levels of 5-50,000 ppm of each flavorant.
  • the paper was incorporated in cigarettes and, upon burning, released a fragrant odor.
  • UV-A and UV-B oil/water sunscreen lotion were prepared with 0,5%.
  • Part A was heated in a reactor to 85° C. Part B was slowly added within 10 min., followed by addition of KOH and 0.5% of the product of Example 5. The emulsion was then cooled and degassed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Cosmetics (AREA)

Abstract

The acrylic acid esters of Formula I are useful for the delivery of organoleptic compounds, especially for flavors, fragrances, masking agents and antimicrobial compounds. They can also deliver fluorescent whitening agents.

Description

FIELD OF INVENTION
The present invention relates to 3-(2-substituted aryl)-acrylic acid esters, especially 3-(2-hydroxyaryl)-acrylic acid esters and 3-(2-aminoaryl)-acrylic acid esters. These compounds are useful as precursors for organoleptic compounds, such as for example, flavors, fragrances and masking agents, antimicrobial compounds and fluorescent whitening agents.
BACKGROUND OF THE INVENTION
A principal strategy currently employed for imparting odors, such as fragrance, to consumer products is to admix the fragrance directly into the product. There are, however, several drawbacks to this strategy. For example, the fragrance material can be too volatile and/or too soluble, resulting in fragrance loss during manufacturing, storage, and use. In addition, many fragrance materials are also unstable over time which, again, results in loss during storage.
In many consumer products it is desirable for the fragrance to be released slowly over time. Microencapsulation and inclusion complexes with cyclodextrins have been used to help decrease volatility, improve stability and provide slow-release properties. These methods are, for a number of reasons, often not successful and/or too expensive to be commercially viable, as for example, in the case of cyclodextrins.
Fragrance precursors for scenting fabrics being washed in the presence of a lipase-containing detergent are described in WO 95/04809. The fragrance precursors contained in the detergent and/or in the softener are cleaved by the lipase and a single active compound. In such a situation, an odoriferous alcohol, aldehyde or ketone is produced. In this system, a prolonged scenting effect on the fabric is obtained. However, the need for a lipase-containing detergent is of limited commercial significance. In many parts of the world, detergents do not contain lipase. Other consumers prefer to use so-called ‘nonbio’ detergents.
Fluorescent whitening agents or brighteners have been added to laundry detergents since the 1950s to help maintain the original brightness of white clothing.
Accordingly, one object of the present invention is to provide new precursors for compounds with different activities. Through these precursors, different activities are imparted to a product by the addition of just one compound of the present invention.
Another object of the invention is to provide new precursor compounds which are stable under transport and storage conditions.
A further object of the present invention is to provide new precursors that supply different active compounds simultaneously or successively.
SUMMARY OF THE INVENTION
The present invention provides compounds of the Formula I
Figure USRE043006-20111206-C00001
wherein A is a benzene or a naphthalene ring; R1 is, or is selected from saturated, unsaturated, straight, branched, alicyclic and/or aromatic C10-C30 hydrocarbon residues which can contain heteroatoms and can be substituted by an ionic substituent, R2 in the 2- or 3-position is, or is selected from hydrogen, a straight or branched C1-C6 residue, an optionally substituted aromatic and/or optionally substituted heterocyclic residue; R3 and R4 are, or selected from hydrogen, a straight or branched C1-C6 alkyl, a C1-C6 alkoxy residue, a substituted or condensed heterocyclic residue, —OH, —NO2, —NH2, —N(C1-C6 alkyl)2, —N(hydroxyalkyl)2, —NHCO2CH3 and/or —NH (heterocycle).
In the present invention, R2, R3 and R4 are the same or different. X is, or is selected from —OH and/or NHR6, wherein R6 is, or is selected from hydrogen, a saturated or unsaturated, straight or branched C1-C20 hydrocarbon and/or an optionally substituted aromatic or heterocyclic residue; and the acrylic double bond is of the E configuration.
The present invention also provides a method for preparing organoleptic, antimicrobial and fluorescent whitening compositions by incorporating into these precursor compounds of Formula I described above.
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides novel 3-(2-substituted aryl)-acrylic acid esters of the Formula I set forth below:
Figure USRE043006-20111206-C00002
wherein
    • A is a benzene or naphthalene ring;
    • R1 is a saturated or unsaturated, straight, branched, alicyclic or aromatic C10-C30 hydrocarbon residue which can contain heteroatoms and can be substituted by an ionic substituent;
    • R2 in the 2- or 3-position is hydrogen, a straight or branched C1-C6 residue, an optionally substituted aromatic or an optionally substituted heterocyclic residue;
    • R3 and R4 are hydrogen, a straight or branched C1-C6 alkyl or C1-C6 alkoxy residue, a substituted or condensed heterocyclic residue, —OH, —NO2, —NH2, —N(C1-C6 alkyl)2, —N(hydroxyalkyl)2, —NHCO2CH3 or —NH(heterocycle);
    • R2, R3 and R4 may be the same or different;
    • X is —OH or NHR6, wherein R6 is hydrogen a saturated or unsaturated, straight or branched C1-C20 hydrocarbon or an optionally substituted aromatic or heterocyclic residue; and the acrylic double bond is of the E configuration.
In the present invention, Formula I includes all possible enantiomers, diastereomers and all mixtures thereof.
In Formula I, R1 is preferably a saturated or unsaturated, straight or branched C10-C30 hydrocarbon residue containing one or more O and/or N atoms and/or C(O) groups and/or alkoxy groups or substituted by an ionic substituent of the formula N(R5)3 +, in which R5 is the residue of a fatty acid or an alkyl group with 1 to 30 carbon atoms are preferred.
In Formula I, R2 is preferably a heterocyclic residue of the formula
Figure USRE043006-20111206-C00003
In Formula I, R3 and/or R4 are preferably hydrogen, —N(C1-C6 alkyl2, —NH2, a five membered heterocyclic residue optionally containing N and/or O atoms, substituted by C1-C6 aliphatic and/or aromatic substituents.
In one embodiment of the present invention, R1 is preferably the residue of an olfactory alcohol of the formula R1OH, of the enol form of an olfactory aldehyde of the formula R1 is an optionally substituted alkyl, alkenyl or arylalkyl residue carrying an 1-alkoxy, 1-aryloxy, or 1-arylakoxy residue.
In the present invention, compounds within the scope of Formula I are mostly or nearly odorless at room temperature, atmospheric conditions and about 20 to 100% relative humidity. Under activating conditions, however, compounds of Formula I are cleaved to form active compounds. For example, the residue of Formula Ia when cleaved forms a coumarin of Formula II.
The structures of Formulae Ia and II are set forth below:
Figure USRE043006-20111206-C00004
wherein X1 is O or NR6; R2, R3, R4 are defined as set forth above.
In the present invention, the coumarins of Formula II have organoleptic, antimicrobial and/or optical brightening activity. Preferably, coumarins of the present invention have olfactory properties.
In the present invention, when R1 is the residue of an olfactory alcohol or the enol form of an olfactory aldehyde or ketone, upon cleavage two active compounds with the above properties can be obtained. Thus, the compounds of Formula I permit the development of useful consumer products with enhanced organoleptic, antimicrobial and/or optical brightening properties. The organoleptic coumarins, alcohols, aldehydes and ketones obtained from the present compounds are useful, for example, in preparing fragrances, flavors, masking agents and antimicrobial agents.
To form active residues from Formula I and Ia, these compounds are subject to activating conditions that lead to the cleavage of thereof. In the present invention, actinic radiation, such as, UV light, including sunlight can be used to activate the compounds of Formula I. Elevated temperatures also function to activate the compounds of Formula I and Ia. For purposes of the present invention, any activating condition may be used, so long as the desired active ingredients are formed by cleavage of compounds of Formula I and Ia to form the desired residue with the proper activity
Another embodiment of the present invention is a method for preparing organoleptic, antimicrobial and fluorescent whitening compositions wherein the compounds of Formula I are precursors for these compounds. For purposes of the present invention, organoleptic precursors include, for example, precursors compatible in flavors, fragrances and odor masking agents.
In the present invention, the esters of formula I can act as fragrance precursors in laundry products. They can also act as precursors for odor masking agents in the same products as the fragrance precursors. They also can act as precursors for antimicrobial agents. In addition, they can also act as precursors for fluorescent whitening agents. The fragrance precursors and the precursors for odor masking agents as well as the flavor precursors of the invention may be used individually in an amount effective to enhance or to mask the characteristic odor or flavor of a material. More commonly, however, the compounds are mixed with other fragrance or flavor components in an amount sufficient to provide the desired odor or flavor characteristics.
Thus, as used herein, an “effective” amount is intended to mean a sufficient quantity of the precursor to obtain the desired effect, i.e., fragrance, odor masking and/or flavoring. Reference is made to the Examples set forth below and to the skill of the art for determining an effective amount of the present inventive compounds in any given situation.
The brightener precursors may also be employed individually in an effective amount where appropriate, and/or mixed with one or more other brightener or colorant substance.
Due to the in situ generation of the active compounds of the present invention, the desired effect is prolonged and the substantivity on different substrates is enhanced. If two active compounds are provided by one ester of the Formula I, they can be generated, depending on the precursor and/or the activating conditions, simultaneously or successively. Further, the precursors of the present invention provide slow release of the active compounds.
Non-limiting examples of alcohols R1OH generated upon cleavage of compounds of Formula I and constituting the residue R1, include amyl alcohol, hexyl alcohol*, 2-hexyl alcohol*, heptyl alcohol*, octyl alcohol*, nonyl alcohol*, decyl alcohol* undecyl alcohol*, lauryl alcohol*, myristic alcohol, 3-methyl-but-2-en-1-ol*, 3-methyl-1-pentanol, cis-3-hexenol*, cis-4-hexenol*, 3,5,5-trimethyl-hexanol, 3,4,5,6,6-pentamethylheptan-2-ol*, citronellol*, geraniol*, oct-1-en-3-ol, 2,5,7-trimethyl-octan-3-ol, 2-cis-3,7-dimethyl-2,6-octadien-1-ol, 6-ethyl-3-methyl-5-octen-1-ol*, 3,7-dimethyl-oct-3,6-dienol*, 3,7-dimethyloctanol*, 7-methoxy-3,7-dimethyl-octan-2-ol*, cis-6-nonenol*, 5-ethyl-2-nonanol, 6,8-dimethyl-2-nonanol*, 2,2,8-trimethyl-7(8)-nonene-3-ol, nona-2,6-dien-1-ol, 4-methyl-3-decen-5-ol*, dec-9-en-1-ol, benzylalcohol, 2-methyl-undecanol, 10-undecen-1-ol, 1-phenyl-ethanol*, 2-phenyl-ethanol*, 2-methyl-3-phenyl-3-propenol, 2-phenyl-propanol*, 3-phenyl-propanol*, 4-phenyl-2-butanol, 2-methyl-5-phenyl-pentanol*, 2-methyl-4-phenyl-pentanol*, 3-methyl-5-phenyl-pentanol*, 2-(2-methylphenyl)-ethanol*, 4-(1-methylethyl)-benzene-methanol, 4-(4-hydroxyphenyl)-butan-2-one*, 2-phenoxy-ethanol*, 4-(1-methylethyl)-2-hydroxy-1-methyl benzene, 2-methoxy-4-methyl-phenol, 4-methyl-phenol, anisic alcohol*, p-tolyl alcohol*, cinnamic alcohol*, vanillin*, ethyl vanillin*, eugenol*, isoeugenol*, thymol, anethol*, decahydro-2-naphthalenol, borneol*, cedrenol*, farnesol*, fenchyl alcohol*, menthol*, 3,7,11-trimethyl-2,6,10-dodecatrien-1-ol, alpha ionol*, tetrahydro ionol*, 2-(1,1-dimethylethyl)cyclohexanol*, 3-(1,1-dimethylethyl) cyclohexanol*, 4-(1,1-dimethylethyl)cyclohexanol*, 4-isopropyl-cyclohexanol, 6,6-dimethyl-bicyclo[3.3.1]hept-2-ene-2-ethanol, 6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-methanol*, p-menth-8-en-3-ol*, 3,3,5-trimethyl-cyclohexanol, 2,4,6-trimethyl-3-cyclohexenyl-methanol*, 4-(1-methylethyl)-cyclohexyl-methanol*, 4-(1,1-dimethylethyl)-cyclohexanol, 2-(1,1-dimethylethyl)-cyclohexanol, 2,2,6-trimethyl-alpha-propyl-cyclohexane propanol*, 5-(2,2,3-trimethyl-3-cyclopentenyl)-3-methylpentan-2-ol*, 3-methyl-5-(2,2,3-trimethylcyclopentyl-3-enyl)pent-4-en-2-ol*, 2-ethyl-4(2,2,3-trimethylcyclopentyl-3-enyl)but-2-en-1-ol*, 4-(5,5,6-trimethylbicyclo[2.2.]hept-2-yl)-cyclohexanol*, 2-(2-methylpropyl)-4-hydroxy-4-methyl-tetrahydropyran*, 2-cyclohexyl-propanol*, 2-(1,1-dimethylethyl)-4-methyl-cyclohexanol*, 1-(2-tert-butyl-cyclohexyloxy)-2-butanol*, 1-(4-isopropyl-cyclohexyl)-ethanol*, 2,6-dimethyl-oct-7-en-2-ol**, 2,6-dimethyl-heptan-2-ol** and 3,7-dimethyl-octa-1,6-dien-3-ol**.
In the list set forth above, the alcohols identified with an asterisk are preferred embodiments, and the alcohols identified with two asterisks are more preferred.
Non-limiting examples of aldehydes R1HO generated upon cleavage a compound of Formula I and constituting the residue R1 thereof include, for example, 2,6,10-trimethylundec-9-enal*, 1,2,3,4,5,6,7,8-octahydro-8,8-dimethyl-2-napthalenecarboxaldehyde tridecanal, 2-[4-(1-methylethyl)phenyl]-ethanal, 2,4-dimethyl-cyclohex-3-ene-1-carbox-aldehyde*, 4-carboxaldehyde-1,3,5-trimethyl-cyclohex-1-ene*, 1-carboxaldehyde-2,4-dimethyl-cyclohex-3-ene*, 1-carboxaldehyde-4-(4-hydroxy-4-methylpentyl)-cyclohex-3-ene*, 3,5,5-trimethyl-hexanal, heptanal*, 2,6-dimethyl-hept-5-enal*, decanal**, dec-9-enal, dec-4-enal, 2-methyldecanal*, undec-10-enal**, undecanal*, dodecanal**, 2-methyl-undecanal**, tridecanal, octanal**, nonanal*, 3,5,5-trimethylhexanal, undec-9-enal**, 2-phenyl-propanal*, 4-methyl-phenyl-acetaldehyde*, 3,7-dimethyl-octanal*, dihydrofarnesal**, 7-hydroxy-3,7-dimethyl-octanal*, 2,6-dimethyl-oct-5-enal, 2-[4-(1-methylethyl)phenyl]-ethanal*, 3-(3-isopropyl-phenyl)-butanal**, 2-(3,7-dimethyoct-6-enoxy)-ethanal, 1-carboxaldehyde-4-(4-methyl-3-pentenyl)-cyclohex-3-ene*, 2,3,5,5-tetramethyl-hexanal, longifolic aldehyde, 2-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)-butanal*, 2-methyl-3-(4-tert-butylphenyl)-propanal**, 4-(1,1-dimethyl-ethyl)-benzene-propanal*, 2-[4-(1-methyl-ethyl)-phenyl]-propanal, alpha-methyl-1,3-benzodioxole-5-propanal*, 3,7-dimethyl-oct-6-enal*, 2-methyl-3-(4-isopropylphenyl)-propionaldehyde*, 4-(4-hydroxy-4-methyl-pentyl)-cyclohex-3-en-1-carboxaldehyde**, alpha-methyl-1,3-benzodioxole-5-propanal*, 1-carboxaldehyde-4-(1,1-dimethylethyl)-cyclohexane, 4-(octahydro-4,7-methano-5H-inden-5-ylidene)-butanal and [(3,7-dimethyl-6-octenyl)-oxy]-acetaldehyde**.
In the list set forth above, the aldehydes identified with an asterisk are preferred embodiments, and the alcohols identified with two asterisks are more preferred.
Non-limiting examples of ketones R1O generated upon cleavage a compound of Formula I and constituting the residue R1 thereof include, for example, 2-heptyl-cyclopentanone, 2,2,6,10-tetrametyltricyclo-[5.4.0.0(6,10)]-undecan-4-one benzylacetone*, carvone*, 1,2,3,5,6,7-hexahydro-1,1,2,3,3-pentamentyl-4H-inden-4-one*, methyl heptenone*, dimethyl octenone*, 2-(butan-2-yl)-cyclohexanone*, 2-hexyl-cyclopent-2-en-1-one*, 2-(1-methylethyl)-5-methyl-cyclohexanone*, 2-(2-methylethyl)-5-methyl-cyclohexanone*, 3-methyl-cyclopentadecanone, 4-tert-pentyl-cyclohexanone*, 3-oxo-2-pentyl-cyclopentane-acetic acid methyl ester**, 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-ethanone* and 3-methyl-5-propyl-cyclohex-2-en-1-one*.
In the list set forth above, the ketones identified with an asterisk are preferred embodiments, and the alcohols identified with two asterisks are more preferred.
Non-limiting examples of fluorescent whitening coumarins generated upon cleavage a compound of Formula I and constituting the residue R1 thereof include, for example, 7-(3-methyl-1H-pyrazol-1-yl)-3-phenyl-2H-1-benzopyran-2-one, 7-(4-methyl-5-phenyl-2H-1,2,3-triazol-2-yl)-3-phenyl-2H-1-benzopyran-2-one, 7-(2H-naphtho[1,2-d]triazol-2-yl)-3-phenyl-2H-1-benzo-pyran-2-one, 3-(1H-pyrazol-1-yl)-7-(2H-1,2,3-triazol-2-yl)-2H-1-benzo-pyran-2-one, 7-(dimethylamino)-1-methyl-3-phenyl-2(1H)-quinolinone, 7-(diethylamino)-1-ethyl-3-phenyl-2(1H)-quinolinone, 7-amino-4-methyl-2H-1-benzopyran-2-one, 7-(dimethylamino)-4-methyl-2H-1-benzopyran-2-one, 7-(diethylamino)-4-methyl-2H-1-benzopyran-2-one, 7-hydroxy-4-methyl-2H-1-benzopyran-2-one and 6,7-dihydroxy-2H-1-benzopyran-2-one.
Non-limiting examples of coumarins of Formula II having olfactory properties generated upon cleavage and constituting the respective residue in the compounds of Formula I, include 2H-1-benzopyran, 3-methyl-benzopyran-2-one, 8-(1,1-dimethylethyl)-6-methyl-benzopyrone, 4-methyl-7-ethoxy-coumarin and 6-methyl-2H-1-benzopyran.
The active coumarins, alcohols, aldehydes and ketones which are generated as a result of the desired cleavage of the acrylic acid esters of Formula I by UV-light and/or by elevated temperatures is exemplary only and is not intended to limit the scope of the present invention in any way.
The compounds of Formula I, preferably, may be employed in preparing sustained release odorants and flavors. The compounds of Formula I also are useful as sustained agents which may be employed to mask or attenuate undesirable odors or to provide additional odors not initially present in consumer products including for example, laundry detergents, fabric softeners, fabric softener sheets, toiletries and cosmetics such as sunscreens.
Further applications of the compounds of Formula I include sustained brighteners and antimicrobial agents in the same products. The brighteners are especially useful for wool, rayon and polyamides. These compounds are also useful for flavoring and aromatizing tobacco products, such as for example, cigarettes.
The amount of the compounds of the present invention required to produce the desired, overall effect varies depending upon the particular compounds of Formula I chosen, the product in which it will be used, and the particular effect desired. The examples teach what amounts are suitable for any desired purpose.
For example, depending upon the selection and concentration of the compound chosen, when a compound of Formula I is added either singly or as a mixture to, for example, a laundry product composition at levels ranging from about 0.001 to about 10% by weight, a coumarin and if desired an odoriferous alcohol, aldehyde or ketone in an organoleptically effective amount is released when the product is used. These newly formed odorant(s) serve to enhance the odor of the fragrance. Depending on the compound of Formula I, an antimicrobial agent and/or a brightener can be released.
Depending upon the selection and concentration, addition of the Formula I compounds, either singly or as a mixture, to cigarette tobacco at levels ranging from about 5 ppm to about 50,000 ppm tends to enhance the smoking flavor and/or mask undesirable smoking odors. An important property of these Formula I compounds is that the flavorant or odorant is covalently bound as a non-volatile compound and the flavorant or odorant is released only when the tobacco product is ignited and burns.
Addition of the compounds of Formula I, either separately, or as a mixture, at levels suitably ranging from about 5 ppm to about 50,000 ppm by weight onto the media enclosing the tobacco, serves to incorporate the odorant/flavorant in the side-stream smoke of the tobacco. Air borne flavorants and/or odorants are thus introduced. This newly formed odorant or flavorant enhances and masks the smoking odors, depending upon selection and use levels of the compounds of Formula I.
As is evident from the above compilation of alcohols, aldehydes, ketones and coumarins, a broad range of odorants or flavors or mixtures can be generated from precursors of the invention. While manufacturing compositions, the precursors of the invention may be used according to methods known to the perfumer, such as e.g. from W. A. Poucher, Perfumes, Cosmetics, Soaps, 2, 7th Edition, Chapman and Hall, London 1974 which is hereby incorporated by reference. The fluorescent whitening agents may be added in similar manner.
The following examples are provided to further illustrate methods of preparation of the compounds of the present invention, as well as certain physical properties and uses thereof. These examples are illustrative only and are not intended to limit the scope of the invention in any way.
EXAMPLES Example 1 (E)-3-(2-Hydroxy-phenyl)-2-methyl-acrylic acid ethyl ester
To a solution of 75.0 g (carbethoxyethylidene)triphenyl phosphorane in 350 ml of toluene, 23.2 g of salicylaldehyde was dropped in at 20° C. while cooling in an ice-bath. After stirring at room temperature for 90 mn., the reaction mixture was diluted with toluene and washed to neutrality with water.
The organic phase was dried, filtered and evaporated to dryness. The resulting yellow oil was purified by chromatography to yield 35.5 g of a colourless solid.
NMR (CDCl3) δ 7.82 (s, 1H), 7.30-6.85 (m, 4H), 6.6 (s, OH), 4.35-4.17 (q, 2H), 2.04 (s, 3H), 1.40-1.28 (t, 3H)
Example 2 (E)-3-(2-Hydroxy-phenyl)-acrylic acid methyl ester
According to the procedure of Example 1, (E)-3-(2-hydroxy-phenyl)-2-methyl-acrylic acid methyl ester was prepared from methyl(triphenyl-phosphoranylidene)acetate and salicylaldehyde.
Example 3 (E)-3-(2-Hydroxy-phenyl)-acrylic acid ethyl ester
According to the procedure of Example 1, (E)-3-(2-hydroxy-phenyl)-2-methyl-acrylic acid methyl ester was prepared from ethyl(triphenyl-phosphoranylidene)acetate and salicylaldehyde.
Example 4 (E)-3(2-Hydroxy-phenyl)-2-methyl-acrylic acid
To a solution of 35.5 g of (E)-3-(2-hydroxy-phenyl)-2-methyl-acrylic acid ethyl ester in 600 ml of ethanol, a solution of 10.66 g of potassium hydroxide in 500 ml of water was dropped in. After refluxing for 5 hours, another 5.0 g of potassium hydroxide was put in and the mixture was refluxed for another 19 hours. Then the reaction mixture was cooled down, diluted with ether and washed to pH 4 with HCl 2N and water. The organic phase was dried, filtered and evaporated to dryness. The resulting colourless crystals were not further purified.
NMR (CDCl3) δ 7.90 (s, 1H), 7.31-6.83 (m, 4H), 2.07 (s, 3H)
Example 5 (E)-3-(2-Hydroxy-phenyl)-2-methyl-acrylic acid 3,7 dimethyl-oct-6-enyl ester
A solution of 6 0 g of (E)-3-(2-hydroxy-phenyl)-2-methyl-acrylic acid, 5.3 g of citronellol and 1 g of p-toluene-sulfonic acid in 150 ml of cyclohexane was refluxed for 6.5 hours using a water separator. Then the reaction mixture was cooled down, diluted with hexane and washed to neutrality with saturated sodium bicarbonate and water. The organic phase was dried, filtered and evaporated to dryness. The resulting yellow oil was purified by chromatography to yield 6.45 g of a colourless oil.
NMR (CDCl3) δ 7.80 (s, 1H), 7.38-6.83 (m, 4H), 6.4 (s, OH), 5.09 (t, 1H) 4.25 (t, 2H), 2.10-1.90 (m, 5H), 1.88-1.08 (m, 1H), 0.93 (d, 3H)
Example 6 (E)-3(2-Hydroxy-phenyl)-2-methyl-acrylic acid phenethyl ester
According to the same procedure of Example 3, (E)-3-(2-hydroxy-phenyl)-2-methyl-acrylic acid phenethyl ester was prepared from 3(2-hydroxy-phenyl)-2-methyl-acrylic acid, phenyl ethyl alcohol and p-toiuenesulfonic acid.
Example 7 3(4-Diethylamino-2-hydroxy-phenyl)-but-2-enoic acid ethyl ester
To a suspension of 5.27 g ethoxycarbonylmethylenetriphenylphosphorane in 10 ml of toluene, a solution of 2.02 g 1-(4-diethylamino-2-hydroxy-phenyl)ethanone (DE 28 44 606) was dropped in at room temperature. Then the reaction mixture was heated to reflux. After refluxing for 31 hours the mixture was cooled down and evaporated to dryness. The resulting dark oil was purified by chromatography to yield a colourless oil.
NMR (CDCl3) δ 7.22-7.09 (m, 1H), 6.57-6.4 2 (m, 1H), 6.32-6 20 (m, 2H), 5 01 (s, 1H), 4.18-4.01 (q, 2H), 3.42-3.24 (q, 4H), 2 49 (s, 3H), 1.31-1.08 (m, 9H).
The compounds of Examples 1-4 yield upon cleavage organoleptic coumarins, Examples 5 and 6 organoleptic coumarins and organoleptic alcohols and Example 7 a brightener coumarin
Example 8 (E)-3-(2-Hydroxy-5-methyl-phenyl)-acrylic acid ethyl ester
A solution of 193.7 g 3-[5-methyl-2-(tetrahydro-pyran-2-yloxy)-phenyl]-acrylic acid ethyl ester (Bunce, R., Moore, J., Org. Prep. Proc., 29(3), 293 (1997)) and 2 g p-toluenesulfonic acid in 2.5 l of ethanol was stirred at room temperature for 24 hours. Then the reaction mixture was concentrated and the residue was diluted with ether, washed with saturated sodium bicarbonate and brine, dried and evaporated to dryness. The resulting yellow solid was recrystallized to yield 97.7 g of colourless crystals.
NMR (CDCl3) δ 8.10-7.93 (d, 1H), 7.27 (s, 1H), 7.10-6.98 (d, 1H), 6.82-6.70 (d, 1H), 6.69-6.55 (d, 1H), 4.38-4.20 (q, 2H), 2.27 (s, 3H), 1.42-1.28 (t, 3H) ppm.
(E)-3-(2-Hydroxy-phenyl)-acrylic acid
To a solution of 100.0 g 3-(2-hydroxy-phenyl)-acrylic acid ethyl ester in 500 ml of ethanol, a solution of 50.9 g potassium hydroxide in 500 ml of water was dropped in at room temperature. After stirring at reflux for 28 hours, the reaction mixture was concentrated. The residue was diluted with 500 ml HCl 2N and extracted with ether. The organic phase was washed with 2N HCl and water, dried and evaporated to dryness. The resulting solid was recrystallized to yield 44.3 g of colourless crystals.
NMR (DMSO) δ 12.2 (br s, 1H), 10.2 (br s, 1H), 7.95-7.75 (d, 1H), 7.65-7.50 (d, 1H), 7.32-7.15 (m, 1H), 6.99-6.76 (m, 2H), 6.62-6.45 (d, 1H) ppm
(E)-3-(2-Hydroxy-phenyl)-acrylic acid dec-9-enyl ester
A mixture of 5.0 g 3-(2-hydroxy-phenyl)-acrylic acid ethyl ester, 6.1 g dec-9-en-1-ol and 1.0 g tetraisopropyl-ortho-titanate was heated to 150° C. removing the ethanol formed. After stirring for 2.5 hours at this temperature, the reaction mixture was cooled, diluted with ether and washed with brine. The organic phase was dried and evaporated to dryness. The resulting oil was Kugelrohr-distilled, crystallized and recrystallized to yield 1.69 g of colourless crystals.
NMR (CDCl3) δ 8.11-7.96 (d, 1H), 7.55-7.40 (d, 1H), 7.32-7.15 (m, 1H), 6.99-6.72 (m, 2H), 6.71-6.57 (d, 1H), 5.93-5.69 (m, 1H), 5 07-4.88 (m, 2H), 4.31-4.15 (t, 2H), 2.12-1.93 (m, 2H), 1.85-1 55 (m, 2H), 1.54-1.15 (m, 10H) ppm
(E)-3-(2-Hydroxy-phenyl)-acrylic acid 2-ethyl-4-(2,2,3-trimethyl-cyclopent-3-enyl)-but-2-enyl ester
According to the same procedure, 3-(2-hydroxy-phenyl)-acrylic acid 2-ethyl-4-(2,2,3-trimethyl-cyclopent-3-enyl)-but-2-enyl ester was prepared from 3-(2-hydroxy-phenyl)-acrylic acid ethyl ester, 2-ethyl-4(2,2,3-trimethyl cyclopentyl-3-en-1-yl)-but-2-en-1-ol and tetraisopropyl-o-titanate.
(E)-3-(2-Hydroxy-5-methyl-phenyl)-acrylic acid 2-ethyl-4-(2,2,3-trimethyl-cyclopent-3-enyl)-but-2-enyl ester
According to the same procedure, 3-(2-hydroxy-5-methyl-phenyl)-acrylic acid 2-ethyl-4-(2,2,3-trimethyl-cyclopent-3-enyl)-but-2-enyl ester was prepared from 3-(2-hydroxy-5-methyl-phenyl)-acrylic acid ethyl ester, 2-ethyl-4(2,2,3-trimethyl cyclopentyl-3-en-1-yl)-but-2-en-1-ol and tetraisopropyl-o-titanate.
(E)-3(2-Hydroxy-5-methyl-phenyl)-acrylic acid 3-methyl-5-phenyl-pentyl ester
According to the same procedure, 3-(2-hydroxy-5-methyl-phenyl)-acrylic acid 3-methyl-5-phenyl-pentyl ester was prepared from 3-(2-hydroxy-.5-methyl-phenyl)-acrylic acid ethyl ester, 3-methyl-5-phenyl-pentanol and tetraisopropyl-o-titanate.
(E)-3(4-Diethylamino-2-hydroxy-phenyl)-but-2-enoic acid dec-9-enyl ester
According to the same procedure, 3-(4-diethylamino-2-hydroxy-phenyl)-but-2-enoic acid dec-9-enyl ester was prepared from 3-(4-diethylamino-2-hydroxy-phenyl)-but-2-enoic acid ethyl ester, dec-9-en-1-ol and tetraisopropyl-o-titanate.
(E)-3-(4-Diethylamino-2-hydroxy-phenyl)-but-2-enoic acid 3-methyl-5-phenyl-pentyl ester
According to the same procedure, 3-(4-diethylamino-2-hydroxy-phenyl)-but-2-enoic acid 3-methyl-5-phenyl-pentyl ester was prepared from 3-(4-diethylamino-2-hydroxy-phenyl)-but-2-enoic acid ethyl ester, 3-methyl-5-phenyl-pentanol and tetraisopropyl-o-titanate.
Example 9 3-[2-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-acrylic acid tert-butyl-dimethyl-silyl ester
To a solution of 5.0 g of (E)-3-(2-hydroxy-phenyl)-acrylic acid and 4.6 g of imidazole in 100 ml of DMF was added at room temperature a solution of 10.1 g of TBDMS-Cl. The reaction mixture was stirred overnight, poured onto 200 ml of cold water and extracted 3× with 150 ml of MTBE. The combined organic phases were dried (MgSO4) and evaporated to dryness. The resulting oil was dried at 0.08 Torr/120-170° C. to remove excess of TBDMS-Cl to yield 11.4 g of 3-[2-(tert-butyl-dimethyl-silanyloxy)-phenyl]-acrylic acid tert-butyl-dimethyl-silyl ester as a yellowish oil.
NMR (CDCl3) δ 7.96 (d, 1H), 7.52 (dd,1H), 7.23 (m, 1H), 6.94 (m, 1H), 6.82 (dd, 1H), 6.37 (d, 1H), 1.00 (s, 9H), 0.97 (s, 9H), 0.32 (s, 6H), 0.22 (s, 6H)
Example 10 3-[2-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-acryloyl chloride
To a 0° C. cold solution of 6.3 g of 3-[2-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-acrylic acid tert-butyl-dimethyl-silyl ester and 8 drops of DMF in 15 ml of CH2Cl2 was added dropwise 2.0 ml of oxalyl chloride. After complete addition the reaction mixture was allowed to warm to room temperature and stirring was continued for 60 h. The reaction mixture was filtered, evaporated to dryness and taken up in MTBE. The solution was cooled in the refrigerator overnight, filtered and evaporated to yield 4.4 g of 3-[2-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-acryloyl chloride.
NMR (CDCl3) δ 8.28 (d, 1H), 7.55 (dd, 1H), 7.35 (m, 1H), 7.01 (m, 1H), 6.87 (dd, 1H), 6.63 (d, 1H), 1.04 (s, 9H), 0.26 (s, 6H)
Example 11 3-(2-Hydroxy-phenyl)-acrylic acid 3-(3-isopropyl-phenyl)-but-1-enyl ester
To a suspension of 0.72 g of NaH (55% in oil), previously washed with hexane, in 22.5 ml of THF was added 1.67 ml of tert-butanol over a period of 12 min. The reaction mixture was stirred at room temperature for 1.25 h, was then cooled to −15° C. and 2 85 g of 3-(3-isopropyl-phenyl)-butanal (Florhydral) was slowly added. Stirring was continued for 45 min. and then this cold enolate solution was added via Teflon canula to a −5° C. cold solution of 4.44 g of 3-[2-(tert-butyl-dimethyl-silanyloxy)-phenyl]-acryloyl chloride in 7.5 ml of THF. After complete addition stirring at −5° C. was continued for 1 h, the reaction mixture was quenched with 80 ml of water/40 ml of brine and was extracted with MTBE. The combined organic phases were washed with water/brine 2:1, dried (MgSO4) and evaporated to dryness to yield 6.65 g of crude 3-[2-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-acrylic acid 3-(3-isopropyl-phenyl)-but-1-enyl ester as a yellowish, viscous oil.
To a 0° C. cold solution of 6 2 g of this oil in 70 ml of THF was added slowly 13.7 ml of a 1M TBAF/THF solution. The reaction mixture was stirred at 0° C. for 1.5 h, poured onto 200 ml of H2O and extracted 3× with 150 ml of MTBE. The combined organic phases were washed with brine, dried (MgSO4) and evaporated to dryness. The resulting oil was purified by chromatography to yield 2.64 g of 3-(2-Hydroxy-phenyl)-acrylic acid 3-(3-isopropyl-phenyl)-but-1-enyl ester in form of a yellowish oil.
NMR (CDCl3) δ 8.12 and 8.01 (d, 1H), 7.50-6.80 (m, 10H), 6.66 and 6.56 (d, 1H), 5.75 and 5.13 (m, 1H), 4.13 (m, CH), 3.53 (m, CH), 2.89 (m, CH), 1.42 (d, 3H), 1.25 (d, 6H)
Example 12 (E)-3-[2(tert-Butyl-dimethyl-silanoxy)-phenyl]-acrylic acid
To a solution of 8.2 g of (E)-3-(2-hydroxy-phenyl)-acrylic acid and 15.2 g of TBDMS-Cl in 10 ml of DMF was added 11.9 g of imidazole and the mixture was stirred at room temperature for 24 h. After aqueous work-up, the bis-silylated product was saponified with 2.1 g of LiOH in THF-H2O for 0.5 h at 0° C. The mixture was concentrated in vacuo and TBDMS-OH removed by extraction with hexane. The aqueous layer was acidified to pH 4 with KHSO4 and extracted with EtOAc. The organic phases were washed with brine, dried (Na2SO4) and evaporated to dryness. The semi-solid residue was suspended in hexane, filtered and the filtrate evaporated to dryness to yield 7.5 g of a pale yellow oil, which solidified upon standing.
NMR (CDCl3) δ 8.08 (d, 1H), 7.46 (dd, 1H), 7.18 (dt, 1H), 6 87 (t, 1H), 6.75 (dd, 1H), 6.31 (d, 1H), 0.93 (s, 9H), 0.13 (s, 6H)
Example 13 (E)-3-(2-Hydroxy-phenyl)-acrylic acid 1-ethoxy-3-(3-isopropyl-phenyl)-butyl ester
A solution of 6.5 g of (E)-3-[2-(tert-Butyl-dimethyl-silanoxy)-phenyl]-acrylic acid and 5.5 g of 1-(3-ethoxy-1-methyl-allyl)-3-isopropyl-benzene, accessible from 3-(3-isopropyl-phenyl)-butyraldehyde via a two step procedure according to P. D. Bartlett and A. A. Frimer, Heterocycles 11, 419-435, (1978), in 25 ml of toluene was heated to reflux and stirred for 16 h. After concentration, the reaction mixture was purified by flash chromatography to yield 7.5 g of the intermediate (E)-3-[2-(tert-Butyl-dimethyl-silanoxy)-phenyl]-acrylic acid 1-ethoxy-3-(3-isopropyl-phenyl)-butyl ester as a pale yellow oil. This was dissolved in 50 ml THF and treated at 0° C. with 4.7 g of TBAF.3H2O. After 20 min., the mixture was concentrated and purification by flash chromatography yielded 2.2 g of the title ester (a mixture of diastereoisomers) as a pale yellow oil.
NMR (CDCl3) d 8.12 and 8.08 (d, 1H), 7.47 (dt, 1H), 7.35 (br s, 1H), 7.31-7.18 (m, 2H), 7.12-6.98 (m, 3H), 6.92 (dt, 1H), 6.83 (dd, 1H), 6.68 and 6.61 (d, 1H), 5.96 and 5.77 (dd, 1H), 3.82-3.65 (m, 1H), 3.63-3.40 (m, 1H), 3.05-2.77 (m, 2H), 2.22-1.95 (m, 2H) and 1.38-1.12 (m, 12H)
Example 14 (E)-3(2-Hydroxy-phenyl)-acrylic acid 3(4-tert-butyl-phenyl)-1-ethoxy-propyl ester
A solution of 3.1 g of (E)-3-[2-(tert-Butyl-dimethyl-silanoxy)-phenyl]-acrylic acid, 3.0 g of 1-tert-butyl-4-(3-ethoxy-2-methyl-allyl)-benzene, accessible from 3-(4-tert-butyl-phenyl)-2-methyl-propionaldehyde via a two step procedure according to P. D. Bartlett and A A. Frimer, Heterocycles 11, 419-435, (1978), and 20 mg of p-TSA in 25 ml of toluene was stirred at 0° C. for 4 h and at room temperature for 14 h. The reaction mixture was partitioned between saturated sodium carbonate and hexane and the organic layer was washed with brine, dried over (Na2SO4) and evaporated to dryness to yield 5.3 g of the crude intermediate (E)-3-[2-(tert-Butyl-dimethyl-silanoxy)-phenyl]-acrylic acid 3-(4-tert-butyl-phenyl)-1-ethoxy-propyl ester as a pale yellow oil. This was dissolved in 20 ml of THF and treated at 0° C. with 3.2 g of solid TBAF-3H2O. After 30 min., the mixture was concentrated and purification by repeated flash chromatography yielded 1.2 g of the title ester (a mixture of diastereoisomers) as a pale yellow oil.
NMR (CDCl3) d 8.17 and 8.13 (d, 1H), 7.50 (ddd, 1H), 7 36-7.18 (m, 4H), 7.11 (br dd, 2H), 6.98-6.83 (m, 2H), 6.73 and 6.69 (d, 1H), 5.94 (t, 1H), 3.92-3.70 (m, 1H), 3.71-3.54 (m, 1H), 3.05-2.81 (m, 1H), 2.52-2.34 (m, 1H), 2.30-2.12 (m, 1H) and 1.31 (s, 9H), 1.33-1.20 (m, 3H), 0.97 and 0.90 (t, 3H)
Example 15
Test cloth was washed with detergent to which one or more of the precursors of Examples 1-14 had been added. The cloth was then line dried. The cloth dried in sunlight had a distinct fragrance note, as determined by a trained panel. In contrast, the cloth dried without sunlight was olfactively neutral.
Example 16
Test cloth was washed with a detergent and then a fabric softener, containing one ore more of the precursors of Examples 1-14, was added to the rinse cycle. The cloth was then line dried. The cloth dried in sunlight had a distinct fragrance note, as determined by a trained panel. In contrast, the cloth dried without sunlight was olfactively neutral.
Example 17
A 1% solution of one or more of the products of Examples 1-14 in ethanol was applied to cigarette papers to produce levels of 5-50,000 ppm of each flavorant. The paper was incorporated in cigarettes and, upon burning, released a fragrant odor.
Example 18
A broad spectrum (UV-A and UV-B) oil/water sunscreen lotion was prepared with 0,5%.
Recipe: % Compound Chemical Name
Part A
2% PARSOL MCX Octyl methoxycinnamate
3% PARSOL 1789 4-4-Buty1-4′methoxy-
dibenzoyl methane
12%  Cetrol LC Coco-caprylate/caprate
4% Dermol 185 Isostearyl neopentanoate
0.25%   Diethyl- PEG-2-stearate
eneglycol
monostearate
1% Cetylalcohol Cetylalcohol
0.25%   MPOB/PPOB Methyl-propylparabene
0.1%   EDTA BD EDTA-sodium salt
1% Amphisol DEA Diethanolamine cetyl-
(Giv.) phosphate
Part B
20%  Permulene TR-1 Acrylate C10-C30 Alkyl-
(+%) acrylate
50.1%   water deion water deion
5% Propyleneglycol 1,2-Propanediol
0.8%   KOH (10%) Potassium hydroxide
Part A was heated in a reactor to 85° C. Part B was slowly added within 10 min., followed by addition of KOH and 0.5% of the product of Example 5. The emulsion was then cooled and degassed
The invention being thus described, it will be obvious that the same may be varied in many ways. Such variations are not to be regarded as a departure from the spirit and scope of the invention and all such modifications are intended to be included within the scope of the following claims.

Claims (21)

1. A compound of Formula I
Figure USRE043006-20111206-C00005
wherein
A is selected from benzene and naphthalene rings;
R1 is a saturated, unsaturated, straight, branched, alicyclic or an aromatic C10-C30 hydrocarbon residue which can contain heteroatoms and can be substituted by an ionic substituent;
R2 in 2- or 3-position is a hydrogen, a straight or branched C1-C6 residue, an optionally substituted aromatic or an optionally substituted heterocyclic residue;
R3 and R4 are a hydrogen, a straight or branched C1-C6 alkyl, a C1-C6 alkoxy residue, a substituted or condensed heterocyclic residue, —OH, —NO2, —NH2, —N(C1-C6 alkyl)2, —N(hydroxyalkyl)2, —NHCO2CH3 or —NH(heterocycle),
wherein R2, R3 and R4 are the same or different;
X is an —OH or NHR6, wherein R6 is a hydrogen, a saturated or unsaturated, straight or branched C1-C20 hydrocarbon, or
an optionally substituted aromatic or heterocyclic residue;
and the acrylic double bond is of the E configuration.
2. A compound according to claim 1 wherein R1 is a saturated, unsaturated, straight or branched C10-C30 hydrocarbon residue comprising one or more O atoms, N atoms, C(O) groups, alkoxy groups and mixtures thereof.
3. A compound according to claim 1 wherein R1 is a saturated, unsaturated, straight or branched C10-C30 hydrocarbon residue substituted by an ionic substituent of Formula NR5 3 +, wherein R5 is a residue of a fatty acid or an alkyl group with 1 to 30 carbon atoms.
4. A compound according to claim 1 wherein R2 is a heterocyclic residue of Formula
Figure USRE043006-20111206-C00006
5. A compound according to claim 1 wherein at least one of R3 and R4 is a five membered heterocyclic residue comprising N atoms and/or O atoms.
6. A compound according to claim 1 wherein at least one of R3 and/or R4 is a hydrogen, —N(C1-C6 alkyl)2, —NH2, or a five membered heterocyclic residue, substituted by C1-C6 aliphatic and/or aromatic substituents.
7. A compound according to claim 1 wherein R2 is hydrogen or methyl.
8. A compound according to claim 1 wherein R1 is a residue of an olfactory alcohol of Formula R1OH.
9. A compound according to claim 1 wherein R1 is a residue of the enol form of an olfactory aldehyde of Formula R1HO.
10. A compound according to claim 1 wherein R1 is a residue of the enol form of an olfactory ketone of Formula R1O.
11. A compound according to claim 1 wherein R1 is a substituted alkyl, an alkenyl or an arylalkyl residue carrying a 1-alkoxy, 1-aryloxy or 1-arylalkoxy residue.
12. A compound according to claim 1 wherein a residue of Formula Ia:
Figure USRE043006-20111206-C00007
is a precursor for a fragrant coumarin.
13. A compound according to claim 1 wherein a residue of Formula Ia
Figure USRE043006-20111206-C00008
is a precursor for a fluorescent whitening coumarin.
14. A compound according to claim 12 wherein R1 is a residue of an olfactory alcohol, an aldehyde or ketone and the residue of Formula Ia
Figure USRE043006-20111206-C00009
is a precursor for a fragrant coumarin.
15. A method for preparing compositions products selected from laundry products, tobacco products, cosmetics and toiletries which provide upon activation organoleptic, antimicrobial or fluorescent whitening properties comprising the step of: incorporating into one of these compositions said products a compound of Formula I:
Figure USRE043006-20111206-C00010
wherein
A is selected from benzene and naphthalene rings;
R1 is selected from: a C10-C30 hydrocarbon residue which may be saturated, unsaturated, straight, branched, alicyclic or an aromatic C10-C30 hydrocarbon residue and which can contain heteroatoms and can be substituted by an ionic substituent, or
R1 is a residue selected from nonyl, 3,5,5-trimethyl-hexanyl, cis-6-nonenyl, 2,6-nonadien-1-yl, 2-phenyl-propyl, 3-phenyl-propyl, 2-(2-methylphenyl)-ethyl, cinnamyl, 2-ethoxy-4-formylphenyl, 4-isopropyl-cyclohexyl, 3,3,5-trimethyl-cyclohexyl, 2-cyclohexyl-propyl, and 2,6-dimethyl-heptan-2-yl;
R2 in the 2- or 3-position is a hydrogen, a straight or branched C1-C6 residue, an optionally substituted aromatic or an optionally substituted heterocyclic residue;
R3 and R4 are a hydrogen, a straight or branched C1-C6 alkyl, a C1-C6 alkoxy residue, a substituted or condensed heterocyclic residue, —OH, —NO2, —NH2, —N(C1-C6 alkyl)2, —N (hydroxyalkyl)2, —NHCO2CH3 or —NH (heterocycle);
wherein R2, R3 and R4 are the same or different;
X is an —OH or NHR6, wherein R6 is a hydrogen, a saturated or unsaturated, straight or branched C1-C20 hydrocarbon, or an optionally substituted aromatic or heterocyclic residue; and
the acrylic double bond is of the E configuration.
16. A method according to claim 15 wherein the precursors are incorporated into laundry products.
17. A method according to claim 15 wherein the precursors are incorporated into tobacco products.
18. A method according to claim 15 wherein the precursors are incorporated into cosmetics and toiletries.
19. A compound of the formula
Figure USRE043006-20111206-C00011
wherein the acrylic double bond is of the E configuration.
20. A method for preparing products selected from laundry products, tobacco products, cosmetics and toiletries which provide upon activation organoleptic, antimicrobial or fluorescent whitening properties comprising the step of:
incorporating into said products a compound of Formula I:
Figure USRE043006-20111206-C00012
wherein A is selected from benzene and naphthalene rings;
R1 is selected from a C10-C30 hydrocarbon residue which may be saturated, unsaturated, straight, branched, alicyclic or aromatic and which can contain heteroatoms and can be substituted by an ionic substituent, or
R1 is a residue selected from: nonyl alcohol, 3,5,5-trimethyl-hexanol, cis-6-nonenol, 2,6-nonadien-1-ol, 2-phenyl-propanol, 3-phenyl-propanol, 2-(2-methylphenyl)-ethanol, cinnamic alcohol, ethyl vanillin, 4-isopropyl-cyclohexanol, 3,3,5-trimethyl-cyclohexanol, 2-cyclohexyl-propanol, and 2,6-dimethyl-heptan-2-ol;
R2 in the 2- or 3-position is a hydrogen, a straight or branched C1-C6 residue, an optionally substituted aromatic or an optionally substituted heterocyclic residue;
R3 and R4 are a hydrogen, a straight or branched C1-C6 alkyl, a C1-C6 alkoxy residue, a substituted or condensed heterocyclic residue —OH —NO2, —-NH2, —N(C1-C6 alkyl)2, —N(hydroxyalkyl)2, —NHCO2CH3 or —NH(heterocycle);
wherein R2, R3 and R4 are the same or different;
X is an —OH or NHR6, wherein R6 is a hydrogen, a saturated or unsaturated, straight or branched C1-C20 hydrocarbon, or an optionally substituted aromatic or heterocyclic residue; and
the acrylic double bond is of the E configuration.
21. A method for preparing products selected from laundry products, tobacco products, cosmetics and toiletries which provide upon activation organoleptic, antimicrobial or fluorescent whitening properties comprising the step of:
incorporating into said products a compound of the formula:
Figure USRE043006-20111206-C00013
wherein the acrylic double bond is of the E configuration.
US10/209,628 1998-02-13 2002-07-30 Aryl-acrylic acid esters Expired - Lifetime USRE43006E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/209,628 USRE43006E1 (en) 1998-02-13 2002-07-30 Aryl-acrylic acid esters

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98810114 1998-02-13
EP98810114 1998-02-13
US09/249,384 US6096918A (en) 1998-02-13 1999-02-12 Aryl-acrylic acid esters
US10/209,628 USRE43006E1 (en) 1998-02-13 2002-07-30 Aryl-acrylic acid esters

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/249,384 Reissue US6096918A (en) 1998-02-13 1999-02-12 Aryl-acrylic acid esters

Publications (1)

Publication Number Publication Date
USRE43006E1 true USRE43006E1 (en) 2011-12-06

Family

ID=8235935

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/249,384 Ceased US6096918A (en) 1998-02-13 1999-02-12 Aryl-acrylic acid esters
US10/209,628 Expired - Lifetime USRE43006E1 (en) 1998-02-13 2002-07-30 Aryl-acrylic acid esters

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/249,384 Ceased US6096918A (en) 1998-02-13 1999-02-12 Aryl-acrylic acid esters

Country Status (10)

Country Link
US (2) US6096918A (en)
JP (2) JP4329885B2 (en)
CN (1) CN1289460C (en)
AU (1) AU725999B2 (en)
BR (1) BR9900443B1 (en)
DE (1) DE69942555D1 (en)
ES (1) ES2347307T3 (en)
ID (1) ID22095A (en)
SG (1) SG93823A1 (en)
ZA (1) ZA99567B (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG93823A1 (en) * 1998-02-13 2003-01-21 Givaudan Roure Int Aryl-acrylic acid esters
US20020094938A1 (en) * 2000-11-08 2002-07-18 The Procter & Gamble Company Photo-labile pro-fragrance conjugates
US20030125220A1 (en) * 2001-09-11 2003-07-03 The Procter & Gamble Company Compositions comprising photo-labile perfume delivery systems
GB0313173D0 (en) * 2003-06-07 2003-07-16 Givaudan Sa Improvements in or related to organic compounds
GB0403115D0 (en) * 2004-02-12 2004-03-17 Givauden Sa Organic compounds
CN100400497C (en) * 2004-12-29 2008-07-09 浙江海正药业股份有限公司 Compounds of class of styracin and cinepazid ester phenylpropionic acid, prepration method and application
US20070275866A1 (en) * 2006-05-23 2007-11-29 Robert Richard Dykstra Perfume delivery systems for consumer goods
MX2009008576A (en) * 2007-02-09 2009-08-18 Procter & Gamble Perfume systems.
CA2744033A1 (en) * 2008-12-01 2010-06-10 The Procter & Gamble Company Perfume systems
US8754028B2 (en) * 2008-12-16 2014-06-17 The Procter & Gamble Company Perfume systems
EP2270124A1 (en) 2009-06-30 2011-01-05 The Procter & Gamble Company Bleaching compositions comprising a perfume delivery system
CA2782613C (en) 2009-12-09 2016-08-23 The Procter & Gamble Company Fabric and home care products
WO2011084463A1 (en) 2009-12-17 2011-07-14 The Procter & Gamble Company Freshening compositions comprising malodor binding polymers and malodor control components
US8987187B2 (en) 2010-06-22 2015-03-24 The Procter & Gamble Company Perfume systems
HUE032069T2 (en) 2010-06-22 2017-10-30 Procter & Gamble Perfume systems
MX2012015187A (en) 2010-07-02 2013-05-09 Procter & Gamble Method for delivering an active agent.
BR112013000101A2 (en) 2010-07-02 2016-05-17 Procter & Gamble filaments comprising active agent nonwoven webs and methods of manufacture thereof
JP5540107B2 (en) 2010-07-02 2014-07-02 ザ プロクター アンド ギャンブル カンパニー Method for making a film from a nonwoven web
CA2803636C (en) 2010-07-02 2017-05-16 The Procter & Gamble Company Detergent product and method for making same
RU2541275C2 (en) 2010-07-02 2015-02-10 Дзе Проктер Энд Гэмбл Компани Filaments, containing non-aromatised active agent, non-woven cloths and methods of obtaining thereof
GB201021050D0 (en) * 2010-12-13 2011-01-26 Givaudan Sa Moc compositions
EP2723841B1 (en) 2011-06-23 2017-01-04 The Procter and Gamble Company Perfume systems
WO2013002786A1 (en) 2011-06-29 2013-01-03 Solae Baked food compositions comprising soy whey proteins that have been isolated from processing streams
FR2985272B1 (en) 2012-01-04 2021-10-22 Procter & Gamble FIBROUS STRUCTURES CONTAINING ACTIVE INGREDIENTS AND HAVING MULTIPLE REGIONS WITH DISTINCT CHARACTERISTICS
GB2498265B (en) 2012-01-04 2015-04-08 Procter & Gamble Fibrous structures comprising particles and methods for making same
US9139802B2 (en) 2012-01-04 2015-09-22 The Procter & Gamble Company Active containing fibrous structures with multiple regions
MX367949B (en) 2013-11-15 2019-09-11 Procter & Gamble Fabric softener composition.
JP6431087B2 (en) 2013-12-09 2018-11-28 ザ プロクター アンド ギャンブル カンパニー Fiber structure containing activator and printed graphics
US20150217015A1 (en) 2014-02-04 2015-08-06 The Procter & Gamble Company Long lasting freshening compositions
EP3416610B1 (en) 2016-02-18 2024-08-14 International Flavors & Fragrances Inc. Microcapsule composition
GB2563524B (en) 2016-03-28 2021-09-01 Procter & Gamble Long lasting and stable freshening compositions and methods of freshening the air
EP3436086A1 (en) 2016-03-28 2019-02-06 The Procter and Gamble Company Long lasting freshening products and method of freshening the air
JP6741458B2 (en) * 2016-03-31 2020-08-19 ライオン株式会社 Textile product treating agent composition
MX2019003078A (en) 2016-09-16 2019-07-08 Int Flavors & Fragrances Inc Microcapsule compositions stabilized with viscosity control agents.
CN110177600B (en) 2017-01-27 2023-01-13 宝洁公司 Active agent-containing articles exhibiting consumer acceptable article application characteristics
US11697906B2 (en) 2017-01-27 2023-07-11 The Procter & Gamble Company Active agent-containing articles and product-shipping assemblies for containing the same
US11697904B2 (en) 2017-01-27 2023-07-11 The Procter & Gamble Company Active agent-containing articles that exhibit consumer acceptable article in-use properties
US11697905B2 (en) 2017-01-27 2023-07-11 The Procter & Gamble Company Active agent-containing articles that exhibit consumer acceptable article in-use properties
US20190093046A1 (en) 2017-09-27 2019-03-28 The Procter & Gamble Company Stable freshening compositions and products comprising the same
US12016963B2 (en) 2019-05-10 2024-06-25 The Procter & Gamble Company Freshening compositions with alkoxylated phenols
US11946018B2 (en) 2019-05-10 2024-04-02 The Procter & Gamble Company Freshening compositions with ethoxylated/propoxylated aromatics
EP3771770A1 (en) 2019-07-29 2021-02-03 The Procter & Gamble Company Antimicrobial freshening compositions
US11485940B2 (en) 2019-12-05 2022-11-01 The Procter & Gamble Company Method of making a cleaning composition
CN114667337A (en) 2019-12-05 2022-06-24 宝洁公司 Cleaning composition
EP4123087A1 (en) 2021-07-19 2023-01-25 The Procter & Gamble Company Freshening composition comprising bacterial spores

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998851A (en) 1973-05-07 1976-12-21 Universal Oil Products Company Preparation of coumarins
US4533691A (en) * 1983-12-12 1985-08-06 Polysar Limited Chlorine dioxide antimicrobial agent for latex
SU1183539A1 (en) 1984-01-04 1985-10-07 Inst Biolog Med Khim Cholesteryl ether of o-coumaric acid as substrate for determining activity of cholesterolesterolesterase
US4748161A (en) * 1984-06-04 1988-05-31 Amano Pharmaceutical Co., Ltd. Triterpenyl esters of organic acids and hypolipidemic agents composed of them
EP0489836A1 (en) * 1989-08-29 1992-06-17 Univ Duke Light activated acyl-enzymes.
US5334750A (en) 1992-04-07 1994-08-02 Bayer Aktiengesellschaft Process for the preparation of cinnamic acid derivatives
WO1995004809A1 (en) 1993-08-09 1995-02-16 Firmenich S.A. Fabric scenting method
US5514710A (en) * 1994-01-11 1996-05-07 Molecular Probes, Inc. Photocleavable derivatives of hydroxyprenesulfonic acids
FR2736354A1 (en) 1995-07-03 1997-01-10 Prospection De La Filiere Lipi Prepn. of ester(s) of cinnamic acid and derivs. - by direct reaction of carboxylic acid and alcohol in presence of lipase acting as carboxyl-esterase, solvents and catalysts
WO1997030687A2 (en) 1996-02-21 1997-08-28 Givaudan-Roure (International) S.A. Fragrance precursors
EP0816322A1 (en) 1996-06-24 1998-01-07 Givaudan-Roure (International) S.A. Fragrance precursors
EP0887335A1 (en) 1997-06-23 1998-12-30 Givaudan-Roure (International) S.A. Precursor compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61243099A (en) * 1985-04-19 1986-10-29 Amano Pharmaceut Co Ltd Triterpene alcohol organic acid ester and production thereof
SG93823A1 (en) * 1998-02-13 2003-01-21 Givaudan Roure Int Aryl-acrylic acid esters

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998851A (en) 1973-05-07 1976-12-21 Universal Oil Products Company Preparation of coumarins
US4533691A (en) * 1983-12-12 1985-08-06 Polysar Limited Chlorine dioxide antimicrobial agent for latex
SU1183539A1 (en) 1984-01-04 1985-10-07 Inst Biolog Med Khim Cholesteryl ether of o-coumaric acid as substrate for determining activity of cholesterolesterolesterase
US4748161A (en) * 1984-06-04 1988-05-31 Amano Pharmaceutical Co., Ltd. Triterpenyl esters of organic acids and hypolipidemic agents composed of them
US4748161B1 (en) * 1984-06-04 1991-10-15 Amano Pharma Co Ltd
EP0489836A1 (en) * 1989-08-29 1992-06-17 Univ Duke Light activated acyl-enzymes.
US5334750A (en) 1992-04-07 1994-08-02 Bayer Aktiengesellschaft Process for the preparation of cinnamic acid derivatives
US5649979A (en) 1993-08-09 1997-07-22 Firmenich S.A. Process for perfuming textiles
WO1995004809A1 (en) 1993-08-09 1995-02-16 Firmenich S.A. Fabric scenting method
US5726345A (en) 1993-08-09 1998-03-10 Firmenich S.A. Process for perfuming textiles
US5514710A (en) * 1994-01-11 1996-05-07 Molecular Probes, Inc. Photocleavable derivatives of hydroxyprenesulfonic acids
FR2736354A1 (en) 1995-07-03 1997-01-10 Prospection De La Filiere Lipi Prepn. of ester(s) of cinnamic acid and derivs. - by direct reaction of carboxylic acid and alcohol in presence of lipase acting as carboxyl-esterase, solvents and catalysts
WO1997030687A2 (en) 1996-02-21 1997-08-28 Givaudan-Roure (International) S.A. Fragrance precursors
EP0816322A1 (en) 1996-06-24 1998-01-07 Givaudan-Roure (International) S.A. Fragrance precursors
EP0887335A1 (en) 1997-06-23 1998-12-30 Givaudan-Roure (International) S.A. Precursor compounds
EP0887336A1 (en) 1997-06-23 1998-12-30 Givaudan-Roure (International) Sa Precursor Compounds

Non-Patent Citations (30)

* Cited by examiner, † Cited by third party
Title
"Photoreactivation of Irreversibly Inhibited Serine Proteinases", by A. Denise Turner et al; J. Am. Chem. Soc. , 1988, 110, pp. 244-250.
Bartlett, et al., (1978) Heterocycles, 11:419-435, "The Reaction of Singlet Oxygen With 1- Methoxycyclohexene".
Beilstein Registry No. 7636064, 1988-2003, Beilstein Institut zur Foerderung der Chemischen Wissenschaften.
Black, J of Chem Soc, Chem Comm, vol. 11, pp. 959-960, 1993. *
Bunce, et al., (1977) Org. Prep. Proc., 29(3):293, "Tetrahydropyranyloxy-Directed Ortho Lithiation of Aromatic Systems. Synthesis of o-Hydroxycinnamate Esters from Phenols".
Cairns, CA 122:55757, abstract only of J of Chem Soc, perkin translations 1: Org and Bio-Org Chem, (21), pp. 3101-3107, 1994. *
Chung, CA 125:142503, abstract only of Korean J of Med Chem, vol. 6(1), pp. 22-34, 1996. *
Coutinho, CA 120:244814, abstract only of J of Indian Chem Soc, vol. 70(1), pp. 51-52, 1993. *
Database XFIRE, Beilstein Informationssysteme GmbH, Frankfurt, DE, the compound with the Beilstein Registry No. 2686917, Jul. 5, 1989.
Database XFIRE, Beilstein Informationssysteme GmbH, Frankfurt, DE, the compound with the Beilstein Registry No. 2686917.
Dey, B.B. et al., (1934) J. Indian Chem., 11:743-749, "Geometrical Inversion in the Acids Derived from the Coumarins".
Ecaterina Nichiforesco et al, "On the assaying of the o-dihydrophenols of caffeic acid type present in artichoke leaves", Annales pharmaceutiques francaise 23, 1965, No. 6, pp. 419-427.
Elenkov et al. Synthesis of Steryl Esters of Phenolic Acids by a Heterogeneous Wittig Reaction, Journal of Natural Products, vol. 58, No. 2, pp. 280-283 (Feb. 1995). *
El-Nagdy, CA 115:71329, abstract only of Acta Chimica Hungarica, vol. 128(1), pp. 35-40, 1991. *
English Language Bibliographic Information for SU1183539 taken from SciFinder.
Galabov, AS. et al., (1998), Z. Naturforsch., 53c:883-887, "Antiviral Activity of Cholersteryl Esters of Cinnamic Acid Derivatives".
Godaard, CA 121:35951, abstract only of Synlett, (4), pp. 235-236, 1994. *
Hemmerle, H. et al., (1997), J. Med. Chem., 40(2):137-145, "Chlorogenic Acid and Synthetic Chlorogenic Acid Derivatives: Novel Inhibitors of Hepatic Glucose-6-phospate Translocase".
Hormi, CA 114:163937, abstract only of J of Chem Soc, Perkins Transactions 1: Org and Bio-Org Chem, (1), pp. 219-221, 1991. *
Kirkham, D.S. et al., (1965) Ann. Appl. Biol., 55:359-371, "Studies of the in vivo activity of esters of o-coumaric and cinnamic acids against apple scab".
Koenigs, J of Am Chem Soc, vol. 115(21), pp. 9371-9379, 1993. *
Luong, M. et al., (1981) Helv. Chim. Acta., 64(8):2741-2745 "Contribution a la phytochimie du genre Gentiana. XXVI. Identification d'une nouvelle di-)-glucosyl cinnamoyl-C-glucosylflavone extraite des feuilles de Gentiana X marcailhouana Ry"(Chemical stress only).
Masuda et al., 7-Hydroxycoumarin Derivatives From the Juice Oil of Citrus Hassaku, Phytochemistry, vol. 31, No. 4, pp. 1363-1366 (1992). *
McCluskey, K.L. et a.., (1927), J. Am. Chem. Soc., 49(1):452-457, "Menthol Studies. I. Menthyl Esters of the Nitro andAminocinnamic Acids".
Ojha, CA 114:81499, abstract only of J. of Institution of Chemists (India), vol. 61(3), pp. 111-113, 1989. *
Saito, CA 121:35389, abstract only of Tetrahedron, vol. 49(43), pp. 9721-9734, 1993. *
Snook, M. et al., (1994) J. Agric. Food Chem., 42(11):2589-2595, "Characterization and Quantitation of Hexadecyl, Octadecyl, and Eicosyl Esters of p-Coumaric Acid in the Vine and Root Latex of Sweet Potato".
Spence, CA 125:189199, 1996, abstract only of J of Am Chem Soc, vol. 118(35), pp. 8336-8343, 1996. *
Terrain, CA 122:L265138, abstract only of J of Org Chem, vol. 60(7), pp. 1981-1984, 1995. *
Toyota, M. et al., (1981) Phytochemistry, 20(10):2359-2366, "Sesquiterpenes from Japanese Liverworts".

Also Published As

Publication number Publication date
CN1227837A (en) 1999-09-08
AU725999B2 (en) 2000-10-26
SG93823A1 (en) 2003-01-21
JP2000063328A (en) 2000-02-29
ES2347307T3 (en) 2010-10-27
BR9900443A (en) 2000-05-02
JP2009114194A (en) 2009-05-28
ZA99567B (en) 1999-07-26
JP4329885B2 (en) 2009-09-09
CN1289460C (en) 2006-12-13
DE69942555D1 (en) 2010-08-19
US6096918A (en) 2000-08-01
ID22095A (en) 1999-09-02
BR9900443B1 (en) 2011-06-28
AU1643099A (en) 1999-10-21

Similar Documents

Publication Publication Date Title
USRE43006E1 (en) Aryl-acrylic acid esters
US6437150B1 (en) Compounds having protected hydroxy groups
EP0936211B1 (en) Aryl-acrylic acid esters useful as precursors for organoleptic compounds
US6479682B1 (en) Compounds having protected hydroxy groups
JPH11246484A (en) Beta-ketoester
US6207857B1 (en) Precursor compounds
EP0887338B1 (en) Carbonates for the delivery of aldehydes and/or ketones
US20100137627A1 (en) 3-(2-Alkoxycarbonyloxy-Phenyl) Acrylic Acid Esters and Their Use as Precursors for the Delivery of Olfactory Compounds
EP0980863A1 (en) Oxime carboxylic acid derivatives
US6369248B1 (en) Fragrance precursor compounds
US6521797B1 (en) Oxime carboxylic acid derivative precursors
JP2002531542A (en) Serine carbonate
MXPA99001281A (en) Acid esters aril-acril
MXPA99007962A (en) Ketones useful as precursors for organoleptic compounds
EP0953562A1 (en) Beta, gamma-unsaturated delta-keto esters

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 12